Cipta Sarana Medika Tbk. vs Sinar Eka Selaras Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 24.02M 24h volume), while Sinar Eka Selaras Tbk. trades at Rp282 (market cap 1.47T, 1.98M 24h volume). The key difference: Sinar Eka Selaras Tbk. is far larger — about 9.1× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (24.02M versus 1.98M). Which is the better fit depends on your goals.
| DKHH | ERAL | |
|---|---|---|
Market Cap | 160.67B | 1.47T |
Volume | 24.02M | 1.98M |
Lot | 240.19K | 19.75K |
Turnover | 1.56B | 555.89M |
Average Price | 65 | 281.42 |
Value | 1.56B | 555.89M |
Indicative Equilibrium Price | 64 | 282 |
Indicative Equilibrium Volume | 1.67K | 487 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Read more on ERAL →